Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer and Stage IV Breast Cancer Clinical Trial Using paclitaxel, trastuzumab, doxorubicin hydrochloride, cyclophosphamide, laboratory biomarker analysis and cytology specimen collection procedure

- The folks at Albert Einstein College of Medicine of Yeshiva University are studying the effects of paclitaxel; trastuzumab; doxorubicin hydrochloride; cyclophosphamide; laboratory biomarker analysis; cytology specimen collection procedure on Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer and Stage IV Breast Cancer in individuals ages 18 years and older. This clinical trial is slated to start June 2013.

Overall Study Contact Info
StatusName Contact Phone
Recruiting

This study is officially titled, "Prospective Tissue Collection in Breast Cancer Patients Receiving Preoperative Systemic Therapy."

Locations

Montefiore Medical Center

Bronx, New York - Recruiting

For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.